Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 210 | -22,827 | -121,290 | -31,544 | -23,376 |
| Depreciation Amortization | 101 | 67 | 34 | 5,893 | 1,943 |
| Income taxes - deferred | 0 | 14 | 7 | 14 | 23 |
| Accounts payable and accrued liabilities | 1,365 | 208 | 470 | -2,436 | -2,094 |
| Other Working Capital | -152,167 | -114,635 | -1,263 | -9,240 | -9,325 |
| Other Operating Activity | 116,479 | 114,688 | 115,840 | 6,633 | 4,915 |
| Operating Cash Flow | $-34,012 | $-22,485 | $-6,202 | $-30,680 | $-27,914 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 25 | 25 |
| Other Investing Activity | 356 | 356 | 356 | -158 | -158 |
| Investing Cash Flow | $356 | $356 | $356 | $-133 | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -21,244 | -21,244 |
| Common Stock Issued | N/A | N/A | N/A | 46,286 | 46,285 |
| Other Financing Activity | 108,140 | 108,140 | 108,612 | 0 | 0 |
| Financing Cash Flow | $108,140 | $108,140 | $108,612 | $25,042 | $25,041 |
| Beginning Cash Position | 7,546 | 7,546 | 7,546 | 13,318 | 13,318 |
| End Cash Position | 82,030 | 93,557 | 110,312 | 7,547 | 10,312 |
| Net Cash Flow | $74,484 | $86,011 | $102,766 | $-5,771 | $-3,006 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,012 | -22,485 | -6,202 | -30,680 | -27,914 |
| Free Cash Flow | -34,012 | -22,485 | -6,202 | -30,680 | -27,914 |